CHEBI:132484 - MLI-2

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name MLI-2
ChEBI ID CHEBI:132484
Definition A member of the class of indazoles that is 1H-indazole that is substituted at position 3 by a 6-(cis-2,6-dimethylmorpholin-4-yl)pyrimidin-4-yl group and at position 5 by a (1-methylcyclopropoxy)group. It is an inhibitor of leucine-rich repeat kinase 2 (LRRK2).
Stars This entity has been manually annotated by the ChEBI Team.
Submitter Margaret Duesbury
Supplier Information
Download Molfile XML SDF
Formula C21H25N5O2
Net Charge 0
Average Mass 379.456
Monoisotopic Mass 379.20083
InChI InChI=1S/C21H25N5O2/c1-13-10-26(11-14(2)27-13)19-9-18(22-12-23-19)20-16-8-15(28-21(3)6-7-21)4-5-17(16)24-25-20/h4-5,8-9,12-14H,6-7,10-11H2,1-3H3,(H,24,25)/t13-,14+
InChIKey ATUUNJCZCOMUKD-OKILXGFUSA-N
SMILES N1(C[C@@H](O[C@@H](C1)C)C)C2=NC=NC(=C2)C3=NNC4=C3C=C(C=C4)OC5(C)CC5
Roles Classification
Chemical Role(s): Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
Biological Role(s): EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of non-specific serine/threonine protein kinase (EC 2.7.11.1), a kinase enzyme involved in phosphorylation of hydroxy group of serine or threonine.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing MLI-2 (CHEBI:132484) has role EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor (CHEBI:50925)
MLI-2 (CHEBI:132484) is a aromatic ether (CHEBI:35618)
MLI-2 (CHEBI:132484) is a cyclopropanes (CHEBI:51454)
MLI-2 (CHEBI:132484) is a indazoles (CHEBI:38769)
MLI-2 (CHEBI:132484) is a morpholines (CHEBI:38785)
MLI-2 (CHEBI:132484) is a pyrimidines (CHEBI:39447)
MLI-2 (CHEBI:132484) is a tertiary amino compound (CHEBI:50996)
Synonym Source
cis-2,6-dimethyl-4-(6-(5-(1-methylcyclopropoxy)-1H-indazol-3-yl)pyrimidin-4-yl)morpholine ChEBI
Citations Waiting for Citations Types Sources
26407721 PubMed citation SUBMITTER
26824392 PubMed citation SUBMITTER
Last Modified
12 July 2016